POLONI, Antonella

POLONI, Antonella  

Dipartimento Scienze Cliniche e Molecolari  

Mostra records
Risultati 1 - 20 di 187 (tempo di esecuzione: 0.028 secondi).
Titolo Data di pubblicazione Autore(i) File
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation. 1-gen-2005 Olivieri, Attilio; Lucesole, M; Capelli, D; Gini, G; Montanari, M; Candela, M; Troiani, E; Scortechini, I; Poloni, Antonella; Leoni, Pietro
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell trasplantation 1-gen-2005 Olivieri, Attilio; Lucesole, M; Capelli, D; Gini, G; Montanari, M; Candela, M; Troiani, E; Scortechini, I; Poloni, Antonella; Leoni, Pietro
Accuracy of bone marrow histochemical TP53 expression compared to the detection of TP53 somatic mutations in patients with myelodysplastic syndromes harbouring a del5q cytogenetic abnormality 1-gen-2021 Oliva, Esther N; Latagliata, Roberto; Sabattini, Elena; Mammì, Corrado; Cuzzola, Maria; D'Errigo, Maria Grazia; Cannatà, Maria Concetta; Bova, Irene; Capodanno, Isabella; Palumbo, Giuseppe Alberto; Pane, Fabrizio; Reda, Gianluigi; Fianchi, Luana; Riva, Marta; Poloni, Antonella
Acute promyelocyte leukemia arose from CALR 1 mutated post essential thrombocythemia- myelofibrosis with splanchnic vein thrombosis: A case report 1-gen-2021 Morsia, E.; Goteri, G.; Torre, E.; Garvey, K. B.; Discepoli, G.; Tassoni, A.; Mancini, S.; Giantomassi, F.; Poloni, A.; Olivieri, A.; Rupoli, S.
Adipocytes properties and crosstalk with immune system in obesity-related inflammation. 1-gen-2017 Maurizi, Giulia; Della Guardia, L; Maurizi, A; Poloni, Antonella
Aging- and Senescence-associated Changes of Mesenchymal Stromal Cells in Myelodysplastic Syndromes 1-gen-2018 Mattiucci, D; Maurizi, G; Leoni, P; Poloni, A
Algoritmi diagnostico-terapeutici in Ematologia 1-gen-2012 Aloe Spiriti, Ma; Angelucci, E; Cortelezzi, A; Finelli, C; Ghio, R; Levis, A; Musto, P; Oliva, En; Poloni, Antonella; Santini, V; Semenzato, G; Specchia, G.
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study 1-gen-2000 Capelli, D; Santini, G; DE SOUZA, C; Poloni, Antonella; Marino, G; Montanari, M; Lucesole, M; Brunori, M; Massidda, D; Offidani, M; Leoni, Pietro; Olivieri, Attilio
AMIFOSTINE CAN REDUCE MUCOSAL DAMAGE AFTER HIGH-DOSE MELPHALANCONDITIONING FOR PERIPHERAL BLOOD PROGENITOR CELL AUTOTRANSPLANT: A RETROSPECTIVE STUDY. EFFECT OF AMIFOSTINE ON MUCOSITIS DURING AUTOLOGOUS PBPC TRANSPLANTATION 1-gen-2000 Capelli, D.; Santini, G.; De Souza, C.; Poloni, Antonella; Marino, G.; Montanari, M.; Lucesole, M.; Brunori, M.; Massidda, D.; Offidani, M.; Leoni, Pietro; Olivieri, Attilio
Apoptotic mechanism activated by blue light and cisplatinum in cutaneous squamous cell carcinoma cells 1-gen-2021 Tartaglione, Maria Fiorella; Eléxpuru Zabaleta, María; Lazzarini, Raffaella; Piva, Francesco; Busilacchi, Elena Marinelli; Poloni, Antonella; Ledda, Caterina; Rapisarda, Venerando; Santarelli, Lory; Bracci, Massimo
Assessment and monitoring of CMV infection in patients receiving a reduced-intensity conditioning allogeneic transplant: comparison of antigenaemia assay with quantitative PCR 1-gen-2005 Olivieri, Attilio; Trappolini, S; Lucesole, M; Capelli, D; Pauri, P; Montanari, M; Poloni, Antonella; Troiani, E; Scortechini, I; Brunori, M; Leoni, Pietro
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 1-gen-2014 Poloni, Antonella; Maurizi, Giulia; Mattiucci, Domenico; Costantini, Benedetta; Mariani, Marianna; Mancini, Stefania; Fanelli, Mirco; Olivieri, Attilio; Leoni, Pietro
Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study 1-gen-2013 Oliva, En; Cuzzola, M; Aloe Spiriti, Ma; Poloni, Antonella; Laganà, C; Rigolino, C; Morabito, F; Galimberti, S; Ghio, R; Cortelezzi, A; Palumbo, G; Sanpaolo, G; Finelli, C; Ricco, A; Volpe, A; Rodà, F; Breccia, M; Alimena, G; Nobile, F; Latagliata, R.
Biosafety evidence for human dedifferentiated adipocytes 1-gen-2015 Poloni, Antonella; Maurizi, G; Mattiucci, D; Busilacchi, E; Mancini, Stefania; Discepoli, G; Amici, A; Falconi, M; Cinti, Saverio; Leoni, Pietro
Bone Marrow "Yellow" and "Red" Adipocytes: Good or Bad Cells? 1-gen-2018 Mattiucci, Domenico; Naveiras, Olaia; Poloni, Antonella
Bone marrow adipocytes support haematopoietic stem cell survival 1-gen-2017 Mattiucci, Domenico; Maurizi, Giulia; Izzi, V; Cenci, L; Ciarlantini, M; Mancini, S; Mensa', Emanuela; Pascarella, R; Vivarelli, Marco; Olivieri, Attilio; Leoni, Pietro; Poloni, Antonella
Bone marrow adipose tissue is a unique adipose subtype with distinct roles in glucose homeostasis 1-gen-2020 Suchacki, Karla J.; Tavares, Adriana A. S.; Mattiucci, Domenico; Scheller, Erica L.; Papanastasiou, Giorgos; Gray, Calum; Sinton, Matthew C.; Ramage, Lynne E.; Mcdougald, Wendy A.; Lovdel, Andrea; Sulston, Richard J.; Thomas, Benjamin J.; Nicholson, Bonnie M.; Drake, Amanda J.; Alcaide-Corral, Carlos J.; Said, Diana; Poloni, Antonella; Cinti, Saverio; Macpherson, Gavin J.; Dweck, Marc R.; Andrews, Jack P. M.; Williams, Michelle C.; Wallace, Robert J.; van Beek, Edwin J. R.; Macdougald, Ormond A.; Morton, Nicholas M.; Cawthorn, Roland H. Stimson and William P.
Bone Marrow Immunological Changes During Treatment with Lenalidomide In Low and Intermediate-1 Risk Myelodysplastic Syndromes with Del(5Q) 1-gen-2010 Oliva, Esther Natalie; Nobile, Francesco; Ronco, Francesca; Alati, Caterina; Morabito, Fortunato; Poloni, Antonella; Cortelezzi, Agostino; Spiriti, Maria Antonietta Aloe; Ricco, Alessandra; Volpe, Antonio; Balleari, Enrico; Sanpaolo, Grazia; Breccia, Massimo; Clissa, Cristina; Alimena, Giuliana; Latagliata, Roberto
Breakthroughs in Preclinical Development of Ataluren (PTC124) As Therapeutic Option for Patients Affected By Shwachman-Diamond Syndrome: Towards the First Clinical Trial 1-gen-2019 Poloni, Antonella
Can the revised IPSS predict response to erythropoietic-stimulating agents in patients with classical IPSS low or intermediate-1 MDS? 1-gen-2013 Santini, V; Schemenau, J; Levis, A; Balleari, E; Sapena, R; Adès, L; Guerci, A; Beyne Rauzy, O; Gourin, Mp; Cheze, S; Stamatoullas, A.; Sanna, A; Gioia, D; Cametti, G; Ferrero, D; Raffoux, E; Rose, C; Poloni, Antonella; Prebet, T; Legros, L; Natarajan Ame, S; Fenaux, P; Germing, U; Dreyfus, F; Park, S.